B型肝炎治療の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21JNE2305)
◆英語タイトル:Global Hepatitis B Treatment Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE2305
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月
◆ページ数:107
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥538,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥807,300見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,076,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、B型肝炎治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(急性、慢性)、用途別市場規模(免疫調節薬、抗ウイルス薬)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・B型肝炎治療の市場動向
・企業の競争状況、市場シェア
・B型肝炎治療の種類別市場規模(急性、慢性)
・B型肝炎治療の用途別市場規模(免疫調節薬、抗ウイルス薬)
・B型肝炎治療の北米市場規模2016-2027(アメリカ、カナダ)
・B型肝炎治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・B型肝炎治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・B型肝炎治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・B型肝炎治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Accord Healthcare Inc.、Apotex Corp.、Arbutus Biopharma、Bristol-Myers Squibb Company、Gilead Sciences、GlaxoSmithKline、Lupin Pharmaceuticals、Merck & Co., Inc.、Par Pharmaceutical、Teva Pharmaceuticals、Zydus Pharmaceuticals)
・結論
【レポートの概要】

It means a treatment of Hepatitis B—— contagious liver infection that can be long lasting.

Market Analysis and Insights: Global Hepatitis B Treatment Market
The global Hepatitis B Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hepatitis B Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hepatitis B Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hepatitis B Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hepatitis B Treatment market.

Global Hepatitis B Treatment Scope and Market Size
Hepatitis B Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hepatitis B Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Acute
Chronic

Segment by Application
Immune Modulator Drugs
Antiviral Drugs

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Accord Healthcare Inc.
Apotex Corp.
Arbutus Biopharma
Bristol-Myers Squibb Company
Gilead Sciences
GlaxoSmithKline
Lupin Pharmaceuticals
Merck & Co., Inc.
Par Pharmaceutical
Teva Pharmaceuticals
Zydus Pharmaceuticals

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hepatitis B Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Acute
1.2.3 Chronic
1.3 Market by Application
1.3.1 Global Hepatitis B Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Immune Modulator Drugs
1.3.3 Antiviral Drugs
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Hepatitis B Treatment Market Perspective (2016-2027)
2.2 Hepatitis B Treatment Growth Trends by Regions
2.2.1 Hepatitis B Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hepatitis B Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Hepatitis B Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Hepatitis B Treatment Industry Dynamic
2.3.1 Hepatitis B Treatment Market Trends
2.3.2 Hepatitis B Treatment Market Drivers
2.3.3 Hepatitis B Treatment Market Challenges
2.3.4 Hepatitis B Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Hepatitis B Treatment Players by Revenue
3.1.1 Global Top Hepatitis B Treatment Players by Revenue (2016-2021)
3.1.2 Global Hepatitis B Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Hepatitis B Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hepatitis B Treatment Revenue
3.4 Global Hepatitis B Treatment Market Concentration Ratio
3.4.1 Global Hepatitis B Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hepatitis B Treatment Revenue in 2020
3.5 Hepatitis B Treatment Key Players Head office and Area Served
3.6 Key Players Hepatitis B Treatment Product Solution and Service
3.7 Date of Enter into Hepatitis B Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Hepatitis B Treatment Breakdown Data by Type
4.1 Global Hepatitis B Treatment Historic Market Size by Type (2016-2021)
4.2 Global Hepatitis B Treatment Forecasted Market Size by Type (2022-2027)

5 Hepatitis B Treatment Breakdown Data by Application
5.1 Global Hepatitis B Treatment Historic Market Size by Application (2016-2021)
5.2 Global Hepatitis B Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Hepatitis B Treatment Market Size (2016-2027)
6.2 North America Hepatitis B Treatment Market Size by Type
6.2.1 North America Hepatitis B Treatment Market Size by Type (2016-2021)
6.2.2 North America Hepatitis B Treatment Market Size by Type (2022-2027)
6.2.3 North America Hepatitis B Treatment Market Size by Type (2016-2027)
6.3 North America Hepatitis B Treatment Market Size by Application
6.3.1 North America Hepatitis B Treatment Market Size by Application (2016-2021)
6.3.2 North America Hepatitis B Treatment Market Size by Application (2022-2027)
6.3.3 North America Hepatitis B Treatment Market Size by Application (2016-2027)
6.4 North America Hepatitis B Treatment Market Size by Country
6.4.1 North America Hepatitis B Treatment Market Size by Country (2016-2021)
6.4.2 North America Hepatitis B Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Hepatitis B Treatment Market Size (2016-2027)
7.2 Europe Hepatitis B Treatment Market Size by Type
7.2.1 Europe Hepatitis B Treatment Market Size by Type (2016-2021)
7.2.2 Europe Hepatitis B Treatment Market Size by Type (2022-2027)
7.2.3 Europe Hepatitis B Treatment Market Size by Type (2016-2027)
7.3 Europe Hepatitis B Treatment Market Size by Application
7.3.1 Europe Hepatitis B Treatment Market Size by Application (2016-2021)
7.3.2 Europe Hepatitis B Treatment Market Size by Application (2022-2027)
7.3.3 Europe Hepatitis B Treatment Market Size by Application (2016-2027)
7.4 Europe Hepatitis B Treatment Market Size by Country
7.4.1 Europe Hepatitis B Treatment Market Size by Country (2016-2021)
7.4.2 Europe Hepatitis B Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Hepatitis B Treatment Market Size (2016-2027)
8.2 Asia-Pacific Hepatitis B Treatment Market Size by Type
8.2.1 Asia-Pacific Hepatitis B Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hepatitis B Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hepatitis B Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Hepatitis B Treatment Market Size by Application
8.3.1 Asia-Pacific Hepatitis B Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hepatitis B Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hepatitis B Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Hepatitis B Treatment Market Size by Region
8.4.1 Asia-Pacific Hepatitis B Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hepatitis B Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Hepatitis B Treatment Market Size (2016-2027)
9.2 Latin America Hepatitis B Treatment Market Size by Type
9.2.1 Latin America Hepatitis B Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Hepatitis B Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Hepatitis B Treatment Market Size by Type (2016-2027)
9.3 Latin America Hepatitis B Treatment Market Size by Application
9.3.1 Latin America Hepatitis B Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Hepatitis B Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Hepatitis B Treatment Market Size by Application (2016-2027)
9.4 Latin America Hepatitis B Treatment Market Size by Country
9.4.1 Latin America Hepatitis B Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Hepatitis B Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Hepatitis B Treatment Market Size (2016-2027)
10.2 Middle East & Africa Hepatitis B Treatment Market Size by Type
10.2.1 Middle East & Africa Hepatitis B Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hepatitis B Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hepatitis B Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Hepatitis B Treatment Market Size by Application
10.3.1 Middle East & Africa Hepatitis B Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hepatitis B Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hepatitis B Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Hepatitis B Treatment Market Size by Country
10.4.1 Middle East & Africa Hepatitis B Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hepatitis B Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Accord Healthcare Inc.
11.1.1 Accord Healthcare Inc. Company Details
11.1.2 Accord Healthcare Inc. Business Overview
11.1.3 Accord Healthcare Inc. Hepatitis B Treatment Introduction
11.1.4 Accord Healthcare Inc. Revenue in Hepatitis B Treatment Business (2016-2021)
11.1.5 Accord Healthcare Inc. Recent Development
11.2 Apotex Corp.
11.2.1 Apotex Corp. Company Details
11.2.2 Apotex Corp. Business Overview
11.2.3 Apotex Corp. Hepatitis B Treatment Introduction
11.2.4 Apotex Corp. Revenue in Hepatitis B Treatment Business (2016-2021)
11.2.5 Apotex Corp. Recent Development
11.3 Arbutus Biopharma
11.3.1 Arbutus Biopharma Company Details
11.3.2 Arbutus Biopharma Business Overview
11.3.3 Arbutus Biopharma Hepatitis B Treatment Introduction
11.3.4 Arbutus Biopharma Revenue in Hepatitis B Treatment Business (2016-2021)
11.3.5 Arbutus Biopharma Recent Development
11.4 Bristol-Myers Squibb Company
11.4.1 Bristol-Myers Squibb Company Company Details
11.4.2 Bristol-Myers Squibb Company Business Overview
11.4.3 Bristol-Myers Squibb Company Hepatitis B Treatment Introduction
11.4.4 Bristol-Myers Squibb Company Revenue in Hepatitis B Treatment Business (2016-2021)
11.4.5 Bristol-Myers Squibb Company Recent Development
11.5 Gilead Sciences
11.5.1 Gilead Sciences Company Details
11.5.2 Gilead Sciences Business Overview
11.5.3 Gilead Sciences Hepatitis B Treatment Introduction
11.5.4 Gilead Sciences Revenue in Hepatitis B Treatment Business (2016-2021)
11.5.5 Gilead Sciences Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Details
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Hepatitis B Treatment Introduction
11.6.4 GlaxoSmithKline Revenue in Hepatitis B Treatment Business (2016-2021)
11.6.5 GlaxoSmithKline Recent Development
11.7 Lupin Pharmaceuticals
11.7.1 Lupin Pharmaceuticals Company Details
11.7.2 Lupin Pharmaceuticals Business Overview
11.7.3 Lupin Pharmaceuticals Hepatitis B Treatment Introduction
11.7.4 Lupin Pharmaceuticals Revenue in Hepatitis B Treatment Business (2016-2021)
11.7.5 Lupin Pharmaceuticals Recent Development
11.8 Merck & Co., Inc.
11.8.1 Merck & Co., Inc. Company Details
11.8.2 Merck & Co., Inc. Business Overview
11.8.3 Merck & Co., Inc. Hepatitis B Treatment Introduction
11.8.4 Merck & Co., Inc. Revenue in Hepatitis B Treatment Business (2016-2021)
11.8.5 Merck & Co., Inc. Recent Development
11.9 Par Pharmaceutical
11.9.1 Par Pharmaceutical Company Details
11.9.2 Par Pharmaceutical Business Overview
11.9.3 Par Pharmaceutical Hepatitis B Treatment Introduction
11.9.4 Par Pharmaceutical Revenue in Hepatitis B Treatment Business (2016-2021)
11.9.5 Par Pharmaceutical Recent Development
11.10 Teva Pharmaceuticals
11.10.1 Teva Pharmaceuticals Company Details
11.10.2 Teva Pharmaceuticals Business Overview
11.10.3 Teva Pharmaceuticals Hepatitis B Treatment Introduction
11.10.4 Teva Pharmaceuticals Revenue in Hepatitis B Treatment Business (2016-2021)
11.10.5 Teva Pharmaceuticals Recent Development
11.11 Zydus Pharmaceuticals
11.11.1 Zydus Pharmaceuticals Company Details
11.11.2 Zydus Pharmaceuticals Business Overview
11.11.3 Zydus Pharmaceuticals Hepatitis B Treatment Introduction
11.11.4 Zydus Pharmaceuticals Revenue in Hepatitis B Treatment Business (2016-2021)
11.11.5 Zydus Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ B型肝炎治療の世界市場規模・現状・予測2021年-2027年(Global Hepatitis B Treatment Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。